Stada Arzneimittel AG - Company Profile

All the data and insights you need on Stada Arzneimittel AG in one report.

$295

Buy Report View Sample

Save hours of research time and resources with
our up-to-date Stada Arzneimittel AG Strategy Report
Understand Stada Arzneimittel AG position in the market,
performance and strategic initiatives.
Gain competitive edge and increase your
chances of success

Stada Arzneimittel AG: Patents

View up-to-date information on Stada Arzneimittel AG patents, including inventor and filing insights.

Publication Identifier	Document Type	Title	Classification-CPC	Publication Date
WO2022175463A1	Application	VERWENDUNG EINER PEMETREXED-KONZENTRATLÖSUNG	A61K31/519; A61K47/20; A61K47/26; A61K9/0019; A61K9/08	August 25, 2022
EP4046626A1	Application	VERWENDUNG EINER PEMETREXED-KONZENTRATLÖSUNG	A61K31/519; A61K47/20; A61K47/26; A61K9/0019; A61K9/08	August 24, 2022
EP3324937B1	Grant	GEBRAUCHSFERTIGE BORTEZOMIB-LÖSUNG	A61K31/69; A61K9/0019; A61K9/08	August 17, 2022
DE202016009131U1	Grant	Gebrauchsfertige Bortezomib-Lösung	A61K31/69; A61K9/0019; A61K9/08	August 15, 2022
WO2022074182A9	Search Report	METHOD OF PRODUCING A RECOMBINANT PROTEIN IN A HOST CELL WHICH HAS A DISABLED RHAMNOSE METABOLISM AS WELL AS EXPRESSION VECTORS, HOST CELLS AND RECOMBINANT PROTEINS THEREOF	C12N15/635; C12N15/70	June 16, 2022

Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Find out more

Name	Count

Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Find out more

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Contact the team or request a demo to find out how our data can drive your business forward